nsclc-egfr-guide-header-image
EGFR exon 20 insertions represent a subset of EGFR-mutant lung cancer and are a heterogeneous group of mutations. Conventional PCR methods can miss EGFR exon 20 insertions, thus molecular profiling with next-generation sequencing (NGS) technology enables precise identification and characterization of exon 20 insertions in clinical research. Download this guide to learn more about the evolving landscape of EGFR in NSCLC.
*
*
*
 
*
*
*
 Yes
 No